Lactulose Market

Lactulose Market Propelled By Increasing Healthcare Expenditure


Lactulose is a synthetic disaccharide used as a laxative and in the treatment of constipation and hepatic encephalopathy. It works by drawing water into the intestines thereby softening the stool. With rising healthcare costs and growing awareness about digestive health, the demand for lactulose is on the rise.

The global Lactulose Market is estimated to be valued at US$ 1.2 billion in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The Global lactulose market size is projected to witness significant growth during the forecast period owing to an increase in healthcare expenditure worldwide. Rapid urbanization and changing lifestyles have led to a rise in digestive issues like constipation which is further boosting the demand for lactulose. With growing health consciousness, consumers are more inclined towards preventive healthcare and ready to spend on products that can aid in digestive health. This rising awareness is expected to work in favor of the lactulose market during the forecast period.

SWOT Analysis

Strength: Lactulose is used to prevent constipation and manage hepatic encephalopathy making it an important clinical treatment option.
Weakness: High cost of lactulose syrup can limit its use in developing regions. Lactulose powder form has poor taste which can lead to non-compliance.
Opportunity: Growing importance of prebiotics in gut health and rising lifestyle diseases offer growth opportunities. Increasing awareness about lactulose benefits gut health can boost demand.
Threats: Availability of alternative treatment options and generic laxatives pose competition. Stringent regulatory approvals for new entrants delay market entry.

Key Takeaways

The global lactulose market is expected to witness high growth.

North America currently dominates the market owing to increasing cases of constipation. Europe follows next on account rising adoption of lactulose for hepatic encephalopathy patients. Asia Pacific is expected to be the fastest growing region due to growing awareness about lactulose health benefits and rising income levels.

Key players operating in the lactulose market are Abbott, Morinaga Milk Industry Co., Ltd., Fresenius Kabi, Valio Ltd., Biofac A/S, Dandong Kangfu Pharmaceutical Co., Ltd., Danone Nutricia, and Lactulose Solutions Ltd. Lactulose is commonly available as syrup and powder formulations. Syrup remains the most popular product form due to ease of administration. However, powder form is gaining traction led by growing preference for convenient packaging and portability.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it